您要查找的是不是：
- This was associated with worse clinical outcome, in particular, higher rates of TLR and stent thrombosis. 与不良临床结果相关，尤其是较高的TLR（靶病变重建率）和支架血栓的发生率。
- Can the problem of late drug-eluting stent thrombosis be solved by the novel recommendation to extend dual antiplatelet therapy to 12 months? 如果依据最新建议将抗血小板凝集药物延长服用至12个月是否能够解决涂药支架血栓的问题?
- The primary end point was the incidence of definite/probable early, subacute, and late stent thrombosis at 6-month follow-up. 在6个月的随访中主要终点是确诊的或者可能早期的、亚急性的和晚期的支架血栓形成的发生。
- Does even temporary discontinuation of anti-platelet therapy post drug-eluting stent implantation predispose patients to late stent thrombosis? 植入涂药支架后，即使只是短暂地停用抗血小板凝集药物治疗是否也会使患者易于发生后期支架血栓?
- The Bern-Rotterdam study looked at the incidence and time course of stent thrombosis in routine clinical practice in a large cohort of consecutive patients with long-term follow-up. 雷帕霉素和紫杉醇洗脱支架的3年期支架内血栓形成发生率在统计学上相当（雷帕霉素洗脱支架为2.;5%25，紫杉醇洗脱支架为3
- Some have affirmed the safety and benefits of drug-eluting stents, while others underscored the risk of potentially fatal late stent thrombosis. 一些结果表明药物洗脱支架是安全有利的，然而另一些结论则强调了使用该支架具有潜在的迟发性支架血栓症的风险性。
- The most frequently reported complications of coronary stents are related to stent thrombosis and anticoagulation problems. 常见的血管支架置放并发症包括支架造成的栓塞及抗血栓药物使用的问题。
- Stent thrombosis after 1 year was more common with both sirolimus-eluting stents and paclitaxel-eluting stents than with bare-metal stents. 与裸金属支架组相比，1年后雷帕霉素和紫杉醇药物涂层支架组更容易发生血栓。
- So, after coronary stenting, aspirin and ticlopidine should be considered for the prevention of serious complication of stent thrombosis. 因此，冠状动脉支架置入术后建议合用两种药物。
- Results: The incidence of 6-month definite/probable stent thrombosis was 3.1%. All stent thromboses were subacute or late. 结果：6个月确诊的或者可能的支架血栓形成率是3.;1%25。所有支架血栓形成是亚急性或者晚期。
- Thus, restricting the use of drug-eluting stents to patients in stable condition with noncomplex coronary stenoses is likely to reduce the risk of late stent thrombosis. 因此，病人病情稳定并且没有复杂的冠状动脉狭窄时限定病人使用药物洗脱支架很有可能降低潜在的支架血栓形成风险性。
- Background The safety of drug-eluting stents has been called into question by recent reports of increased stent thrombosis, myocardial infarction, and death. 背景：因支架内血栓发生率、心肌梗死以及死亡率增加，药物洗脱支架的安全性在进来的报告中受到了置疑。
- The present study investigated differences of the stented segment between patients with and without very late stent thrombosis with the use of intravascular ultrasound. 我们的实验通过血管内超声观察发生和未发生迟发性支架血栓的病人在安装支架部位的不同。
- During the 12-month follow-up, no stent thromboses, MIs, or deaths were obsered. 在12个月的随访期里，未出现支架内血栓形成、心肌梗死或者是死亡。
- The present study inestigated differences of the stented segment between patients with and without ery late stent thrombosis with the use of intraascular ultrasound. 我们的实验通过血管内超声观察发生和未发生迟发性支架血栓的病人在安装支架部位的不同。
- During the 12-month follow-up, no stent thromboses, MIs, or deaths were observed. 在12个月的随访期里，未出现支架内血栓形成、心肌梗死或者是死亡。
- An independent endpoint review committee adjudicated all reported major adverse cardiovascular events, stent thromboses, and target-vessel revascularizations. 患者所发生的主要恶性心血管事件、支架内血栓形成和靶血管的血管形成术等状况由专门的委员会最终判定。
- Their results showed a "sustained reduction in the need for reintervention after the use of sirolimus-eluting stents," and a risk of stent thrombosis no lower than observed with bare-metal stents. 结果表明“使用西罗莫司洗脱支架后介入治疗的需求持续减少”，并且和使用裸露的金属支架相比，病人发生支架血栓的风险性也不低。
- Early and Late Stent Thrombosis 'Are Distinct Entities' 早期和晚期的支架血栓形成明显不同
- By the stent, such as corbel parts and accessories. 并由支架、托臂和附件等部分组成。
- 今日热词
-
- 深远海浮式风电平台 - deep-sea floating wind power platform
-
- 京雄高速公路 - Beijing-Xiongan expressway
-
- 农业及相关产业增加值 - the added value of agriculture and related industries
